Dissemin is shutting down on January 1st, 2025

Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 29(118), 2021

DOI: 10.1073/pnas.2025769118

Links

Tools

Export citation

Search in Google Scholar

Methylation of viral mRNA cap structures by PCIF1 attenuates the antiviral activity of interferon-β

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Significance The cap structure present at the 5′ end of eukaryotic messenger RNAs (mRNAs) regulates RNA stability, translation, and marks mRNA as self, thereby impeding recognition by the innate immune system. Cellular transcripts beginning with adenosine are additionally modified at the N6 position of the 2’-O methylated cap-proximal residue by the methyltransferase PCIF1 to m 7 Gpppm 6 A m . We define a function for this N6-adenosine methylation in attenuating the interferon-β–mediated suppression of viral infection. Cells lacking PCIF1, or defective in its enzymatic activity, augment the cell-intrinsic suppressive effect of interferon-β treatment on vesicular stomatitis virus (VSV) and rabies virus (RABV) gene expression. VSV and RABV mRNAs are efficiently methylated by PCIF1, suggesting this contributes to viral evasion of innate immune suppression.